| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
|
MELLIN GW, 1962, NEW ENGL J MED, V267, P1184 MELLIN GW, 1962, NEW ENGL J MED, V267, P1238 LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555 LENZ W, 1962, DEUT MED WOCHENSCHR, V87, P1232 KUNZ W, 1956, ARZNEIMITTEL-FORSCH, V6, P426 SHESKIN J, 1965, LEPROSY REV, V36, P183 WIEDEMANN HR, 1961, MED WELT, V37, P1863 BECKMANN R, 1962, ARZNEIMITTEL-FORSCH, V12, P1095 |
Nodes: 2685,
Authors: 6203,
Journals: 662,
Outer References: 16023,
Words: 3995
Collection span: 1956 - 2004
View: Overview. Sorted by journal name.
Page 8: 1 2 3 4 5 6 7 8 9
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 2101 | 1 | 41 | 2663 2004 LEUKEMIA RESEARCH 28(8):791-803 Raza A; Buonamici S; Lisak L; Tahir S; Li DL; Imran M; Chaudary NI; Pervaiz H; Gallegos JA; Alvi MI; Mumtaz M; Gezer S; Venugopal P; Reddy P; Galili N; Candoni A; Singer J; Nucifora G Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression | 0 | 0 |
| 2102 | 0 | 1 | 1977 2001 LIBRARY JOURNAL 126(7):126-126 Kupferberg N Dark remedy: The impact of thalidomide and its revival as a vital medicine. | 0 | 0 |
| 2103 | 6 | 9 | 157 1962 LIFE SCIENCES (7):333-336 SMITH RL; WILLIAMS RAD; WILLIAMS RT PHTHALOYLISOGLUTAMINE, A METABOLITE OF THALIDOMIDE | 2 | 3 |
| 2104 | 3 | 7 | 290 1964 LIFE SCIENCES 3(9):987-992 FABRO S; SCHUMACHER H; SMITH RL; WILLIAMS RT TERATOGENIC ACTIVITY OF THALIDOMIDE AND RELATED COMPOUNDS | 20 | 34 |
| 2105 | 11 | 27 | 1069 1992 LIFE SCIENCES 51(26):2107-2116 NEUBERT R; NOGUEIRA AC; NEUBERT D THALIDOMIDE AND THE IMMUNE-SYSTEM .2. CHANGES IN RECEPTORS ON BLOOD-CELLS OF A HEALTHY VOLUNTEER | 32 | 38 |
| 2106 | 10 | 27 | 1152 1994 LIFE SCIENCES 55(2):77-92 NOGUEIRA AC; NEUBERT R; HELGE H; NEUBERT D THALIDOMIDE AND THE IMMUNE-SYSTEM .3. SIMULTANEOUS UP-REGULATION AND DOWN-REGULATION OF DIFFERENT INTEGRIN RECEPTORS ON HUMAN WHITE BLOOD-CELLS | 56 | 63 |
| 2107 | 7 | 45 | 1153 1994 LIFE SCIENCES 56(6):407-420 NEUBERT R; HELGE H; NEUBERT D THALIDOMIDE AND THE IMMUNE-SYSTEM .4. DOWN-REGULATION OF THE CD26 RECEPTOR, PROBABLY INVOLVED IN THE BINDING OF HIV COMPONENTS TO T-CELLS IN PRIMATES | 3 | 4 |
| 2108 | 18 | 38 | 1210 1995 LIFE SCIENCES 58(4):295-316 Neubert R; Hinz N; Thiel R; Neubert D Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide | 3 | 7 |
| 2109 | 14 | 24 | 1211 1995 LIFE SCIENCES 58(4):337-348 Nogueira AC; Neubert R; Felies A; JacobMuller U; Frankus E; Neubert D Thalidomide derivatives and the immune system .6. Effects of two derivatives with no obvious teratogenic potency on the pattern of integrins and other surface receptors on blood cells of marmosets | 2 | 3 |
| 2110 | 9 | 16 | 1756 2000 LIFE SCIENCES 66(2):133-141 Thiel R; Kastner U; Neubert R Expression of adhesion receptors on rat limb bud cells and results of treatment with a thalidomide derivative | 3 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2111 | 3 | 13 | 1757 2000 LIFE SCIENCES 67(4):457-461 Thiele A; Thormann M; Hofmann HJ; Naumann WW; Eger K; Hauschildt S A possible role of N-cadherin in thalidomide teratogenicity | 4 | 6 |
| 2112 | 24 | 33 | 1285 1996 LUPUS 5(4):257-258 Stevens RJ The place of thalidomide in the treatment of inflammatory disease | 3 | 5 |
| 2113 | 3 | 10 | 1578 1999 LUPUS 8(3):248-249 Rua-Figueroa I; Erausquin C; Naranjo A; Carretero-Hernandez G; Rodriguez-Lozano C; De la Rosa P Pustuloderma during cutaneous lupus treatment with thalidomide | 3 | 5 |
| 2114 | 32 | 42 | 1978 2001 LUPUS 10(3):188-192 Karim MY; Ruiz-Irastorza G; Khamashta MA; Hughes GRV Update on therapy - thalidomide in the treatment of lupus | 6 | 13 |
| 2115 | 18 | 38 | 2262 2002 LUPUS 11(2):67-70 Piette JC; Sbai A; Frances C Warning: thalidomide-related thrombotic risk potentially concerns patients with lupus | 3 | 5 |
| 2116 | 7 | 10 | 2531 2003 LUPUS 12(9):723-724 Tektonidou MG; Vlachoyiannopoulos PG Antiphospholipid syndrome triggered by thalidomide in a patient with discoid lupus erythematosus | 0 | 0 |
| 2117 | 5 | 7 | 2664 2004 LUPUS 13(6):481-482 Pagnoux C; Lutz-Zarrouk V; Michel M; Schaeffer A; Godeau B Cerebral venous thrombosis in a patient with antiphospholipid syndrome treated with thalidomide | 0 | 0 |
| 2118 | 6 | 6 | 1369 1997 M S-MEDECINE SCIENCES 13(4):595-596 Audit CO; Aimar C Thalidomide-induced teratogenesis. | 0 | 0 |
| 2119 | 2 | 4 | 245 1963 MAYO CLINIC PROCEEDINGS 38(23):518-& WEIDMAN WH; YOUNG HH; ZOLLMAN PE EFFECT OF THALIDOMIDE ON UNBORN PUPPY | 5 | 3 |
| 2120 | 7 | 16 | 1758 2000 MAYO CLINIC PROCEEDINGS 75(8):842-844 Federman GL; Federman DG Recalcitrant pyoderma gangrenosum treated with thalidomide | 5 | 12 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2121 | 10 | 28 | 1759 2000 MAYO CLINIC PROCEEDINGS 75(9):897-901 Rajkumar SV; Fonseca R; Dispenzieri A; Lacy MQ; Lust JA; Witzig TE; Kyle RA; Gertz MA; Greipp PR Thalidomide in the treatment of relapsed multiple myeloma | 56 | 85 |
| 2122 | 2 | 4 | 2263 2002 MAYO CLINIC PROCEEDINGS 77(12):1395-1395 Crawford CL Thalidomide-induced neuropathy | 1 | 1 |
| 2123 | 2 | 2 | 2264 2002 MAYO CLINIC PROCEEDINGS 77(12):1395-1395 Rajkumar SV; Gertz MA; Kyle RA; Greipp PR Thalidomide-induced neuropathy - In reply | 0 | 0 |
| 2124 | 23 | 39 | 2532 2003 MAYO CLINIC PROCEEDINGS 78(1):34-39 Kumar S; Gertz MA; Dispenzieri A; Lacy MQ; Geyer SM; Iturria NL; Fonseca R; Hayman SR; Lust JA; Kyle RA; Greipp PR; Witzig TE; Rajkumar SV Response rate, durability of response, and survival after thalidomide therapy for relapsed multiple myeloma | 9 | 20 |
| 2125 | 15 | 44 | 2665 2004 MAYO CLINIC PROCEEDINGS 79(7):857-858 Silver RT Myelofibrosis: Thalidomide finds a new disease | 0 | 0 |
| 2126 | 12 | 22 | 2666 2004 MAYO CLINIC PROCEEDINGS 79(7):875-882 Richardson P; Schlossman R; Jagannath S; Alsina M; Desikan R; Blood E; Weller E; Mitsiades C; Hideshima T; Davies F; Doss D; Freeman A; Bosch J; Patin J; Knight R; Zeldis J; Dalton W; Anderson K Thalidomide for patients with relapsed multiple myeloma after high-dose chemotherapy and stem cell transplantation: Results of an open-label Multicenter phase 2 study of efficacy, toxicity, and biological activity | 0 | 0 |
| 2127 | 21 | 42 | 2667 2004 MAYO CLINIC PROCEEDINGS 79(7):883-889 Mesa RA; Elliott MA; Schroeder G; Tefferi A Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia | 1 | 1 |
| 2128 | 59 | 83 | 2668 2004 MAYO CLINIC PROCEEDINGS 79(7):899-903 Rajkumar SV Thalidomide: Tragic past and promising future | 0 | 0 |
| 2129 | 0 | 9 | 49 1961 Med Welt 37:1863-1866 WIEDEMANN HR Indications of a current increase of hypoplastic and aplastic deformities of the extremities | 37 | 86 |
| 2130 | 14 | 36 | 826 1983 MEDICAL HYPOTHESES 10(4):437-443 HENDLER SS; MCCARTY MF THALIDOMIDE FOR AUTOIMMUNE-DISEASE | 13 | 14 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2131 | 26 | 64 | 999 1989 MEDICAL HYPOTHESES 30(2):105-109 GUNZLER V THALIDOMIDE - A THERAPY FOR THE IMMUNOLOGICAL CONSEQUENCES OF HIV INFECTION | 4 | 6 |
| 2132 | 23 | 108 | 1370 1997 MEDICAL HYPOTHESES 49(2):123-131 McCarty MF Thalidomide may impede cell migration in primates by down-regulating integrin beta-chains: Potential therapeutic utility in solid malignancies, proliferative retinopathy, inflammatory disorders, neointimal hyperplasia, and osteoporosis | 17 | 31 |
| 2133 | 13 | 66 | 1463 1998 MEDICAL HYPOTHESES 50(4):313-318 Argiles JM; Carbo N; Lopez-Soriano FJ Was tumour necrosis factor-alpha responsible for the fetal malformations associated with thalidomide in the early 1960s? | 11 | 12 |
| 2134 | 5 | 14 | 1579 1999 MEDICAL HYPOTHESES 53(1):76-77 Sastry PSRK Inhibition of TNF-alpha synthesis with thalidomide for prevention of acute exacerbations and altering the natural history of multiple sclerosis | 5 | 7 |
| 2135 | 1 | 11 | 2533 2003 MEDICAL HYPOTHESES 60(4):513-514 Namazi MR The potential efficacy of thalidomide in the treatment of recalcitrant alopecia areata | 0 | 0 |
| 2136 | 0 | 0 | 46 1961 MEDICAL JOURNAL OF AUSTRALIA 1(23):868-& [Anon] THALIDOMIDE | 0 | 0 |
| 2137 | 0 | 0 | 47 1961 MEDICAL JOURNAL OF AUSTRALIA 2(24):966-& POOLE WG THALIDOMIDE | 0 | 0 |
| 2138 | 0 | 0 | 48 1961 MEDICAL JOURNAL OF AUSTRALIA 2(26):1030-& MCBRIDE WG CONGENITAL ABNORMALITIES AND THALIDOMIDE | 3 | 4 |
| 2139 | 0 | 0 | 158 1962 MEDICAL JOURNAL OF AUSTRALIA 1(14):533-& THOMPSON HL CONGENITAL ABNORMALITIES AND THALIDOMIDE | 0 | 0 |
| 2140 | 0 | 0 | 159 1962 MEDICAL JOURNAL OF AUSTRALIA 1(17):649-& VICKERS TH CONGENITAL ABNORMALITIES AND THALIDOMIDE | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2141 | 0 | 0 | 160 1962 MEDICAL JOURNAL OF AUSTRALIA 1(19):735-& PRYOR CH CONGENITAL ABNORMALITIES AND THALIDOMIDE | 0 | 0 |
| 2142 | 0 | 0 | 161 1962 MEDICAL JOURNAL OF AUSTRALIA 1(24):949-& LUMER RH CONGENITAL ABNORMALITIES AND THALIDOMIDE | 1 | 1 |
| 2143 | 0 | 0 | 162 1962 MEDICAL JOURNAL OF AUSTRALIA 2(7):267-& [Anon] THALIDOMIDE SITUATION | 0 | 0 |
| 2144 | 0 | 0 | 163 1962 MEDICAL JOURNAL OF AUSTRALIA 2(7):273-& LOVELL R CONGENITAL ABNORMALITIES AND THALIDOMIDE | 0 | 0 |
| 2145 | 0 | 0 | 164 1962 MEDICAL JOURNAL OF AUSTRALIA 2(14):567-& TUREK MA THALIDOMIDE SITUATION | 0 | 0 |
| 2146 | 0 | 0 | 165 1962 MEDICAL JOURNAL OF AUSTRALIA 2(17):677-& [Anon] CARE OF THALIDOMIDE BABIES | 0 | 0 |
| 2147 | 0 | 1 | 653 1977 MEDICAL JOURNAL OF AUSTRALIA 2(23):785-785 GERAGHTY PF THALIDOMIDE AND POLYMORPHOUS LIGHT ERUPTION | 0 | 0 |
| 2148 | 2 | 7 | 1024 1990 MEDICAL JOURNAL OF AUSTRALIA 152(3):148-149 BROWN MA; FARRELL C; NEWTON P; CHILD RP THALIDOMIDE, PREGNANCY AND RENAL-FAILURE | 0 | 0 |
| 2149 | 2 | 4 | 1025 1990 MEDICAL JOURNAL OF AUSTRALIA 152(7):382-383 GEORGHIOU PR; KEMP RJ HIV-ASSOCIATED ESOPHAGEAL ULCERS TREATED WITH THALIDOMIDE | 6 | 9 |
| 2150 | 4 | 6 | 2265 2002 MEDICAL JOURNAL OF AUSTRALIA 177(5):278-278 McBride W Thalidomide and cancer | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2151 | 1 | 2 | 2534 2003 MEDICAL JOURNAL OF AUSTRALIA 178(8):413-413 Elwood JM Thalidomide and cancer? | 0 | 0 |
| 2152 | 0 | 2 | 2669 2004 MEDICAL JOURNAL OF AUSTRALIA 180(4):199-200 Crawford CL Licensing thalidomide in Australia | 0 | 0 |
| 2153 | 0 | 3 | 2670 2004 MEDICAL JOURNAL OF AUSTRALIA 180(4):200-200 Tattersall MHN Licensing thalidomide in Australia - Reply | 0 | 0 |
| 2154 | 5 | 5 | 2671 2004 MEDICAL JOURNAL OF AUSTRALIA 180(7):366-367 Coutsouvelis J; Corallo CE Thalidomide-induced bradycardia and its management | 0 | 0 |
| 2155 | 0 | 0 | 1464 1998 MEDICAL LETTER ON DRUGS AND THERAPEUTICS 40(1038):103-104 [Anon] Thalidomide | 1 | 0 |
| 2156 | 7 | 17 | 2266 2002 MEDICAL ONCOLOGY 19(2):79-86 Merup M; Kutti J; Birgergard G; Mauritzson N; Bjorkholm M; Markevarn B; Malm C; Westin J; Palmblad J; Samuelsson J; Swedish Natl Study Grp Chronic Mye Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia | 4 | 5 |
| 2157 | 9 | 23 | 2267 2002 MEDICAL ONCOLOGY 19(4):219-226 Srkalovic G; Elson P; Trebisky B; Karam MA; Hussein MA Use of melphalan, thalidomide, and dexamethasone in treatment of refractory and relapsed multiple myeloma | 1 | 2 |
| 2158 | 5 | 25 | 2535 2003 MEDICAL ONCOLOGY 20(4):397-401 Fraiman G; Ganti AK; Potti A; Mehdi S Angiosarcoma of the small intestine - Possible role for thalidomide? | 0 | 0 |
| 2159 | 0 | 0 | 1000 1989 MEDICINA CLINICA 92(15):571-571 CODINA C THALIDOMIDE 1989 | 1 | 1 |
| 2160 | 0 | 0 | 1026 1990 MEDICINA CLINICA 94(16):638-639 BERNARDO P; ARRIZABALAGA J; IRIBARREN JA; GARDE C EFFECTIVENESS OF THALIDOMIDE IN NONSPECIFIC ESOPHAGEAL ULCERS IN PATIENTS WITH HUMAN IMMUNODEFICIENCY SYNDROME | 3 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2161 | 0 | 0 | 1049 1991 MEDICINA CLINICA 97(2):79-79 TERCEDOR J; ORTEGO N; RODENAS JM; HERNANDEZ J TREATMENT OF RECURRENT APHTHAE WITH THALIDOMIDE IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME | 1 | 1 |
| 2162 | 8 | 10 | 1104 1993 MEDICINA CLINICA 100(14):557-557 GARCIAALBEA E; CABRERA F; TEJEIRO J; JIMENEZJIMENEZ FJ MIGRAINE AND THALIDOMIDE | 0 | 0 |
| 2163 | 3 | 10 | 1105 1993 MEDICINA CLINICA 101(4):158-158 PIZARRO A; PINILLA J; GARCIATOBARUELA A THERAPY WITH THALIDOMIDE AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION | 0 | 1 |
| 2164 | 7 | 10 | 2672 2004 MEDICINA CLINICA 122(15):595-596 Cistero B; Sala M; Soler A; Garcia N Thalidomide in the treatment of recurrent plasmocitomas in an HIV-infected patient | 0 | 0 |
| 2165 | 1 | 3 | 246 1963 MEDICINA EXPERIMENTALIS 8(2):66-& GIURGEA C; MOEYERSOONS F ACTION OF THALIDOMIDE ON EEG OF CONSCIOUS, UNRESTRAINED RABBIT | 2 | 8 |
| 2166 | 6 | 15 | 291 1964 MEDICINA EXPERIMENTALIS 11(2):119-& BERGSTROM RM; BERGSTROM L; PUTKONEN P; SAINIO K EFFECTS OF THALIDOMIDE ON ELECTRICAL ACTIVITY OF BRAIN IN INTRAUTERINE GUINEA-PIG FOETUS | 1 | 3 |
| 2167 | 0 | 0 | 928 1986 MEDICINA-BUENOS AIRES 46(5):528-528 BOTTASSO OA; MORINI JC; REGGIARDO Z ANTIBODIES AGAINST BCG GLYCOLIPIDS IN LEPROMATOUS PATIENTS TREATED WITH THALIDOMIDE OR LEPROUS KNOTTED ERYTHEMA | 0 | 0 |
| 2168 | 4 | 10 | 1760 2000 MEDICINA-BUENOS AIRES 60:61-65 Politi PM Thalidomide. Clinical trials in cancer. | 1 | 1 |
| 2169 | 0 | 2 | 707 1979 MEDICINE SCIENCE AND THE LAW 19(4):272-272 [Anon] EUROPEAN COURT AND THALIDOMIDE | 0 | 0 |
| 2170 | 10 | 32 | 2673 2004 MELANOMA RESEARCH 14(1):57-62 Pawlak WZ; Legha SS Phase II study of thalidomide in patients with metastatic melanoma | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2171 | 2 | 19 | 1465 1998 METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY 20(9):739-742 Guinan P; Shaw M; Mirochnik Y; Slobodskoy L; Ray V; Rubenstein M Paclitaxel is more effective than thalidomide in inhibiting LNCaP tumor growth in a prostate cancer model | 2 | 5 |
| 2172 | 7 | 38 | 2268 2002 MICROBES AND INFECTION 4(11):1193-1202 Teo SK; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD Thalidomide in the treatment of leprosy | 7 | 9 |
| 2173 | 6 | 23 | 1212 1995 MICROBIAL PATHOGENESIS 19(4):245-255 BURROUGHS MH; TSENOVABERKOVA L; SOKOL K; OSSIG J; TUOMANEN E; KAPLAN G EFFECT OF THALIDOMIDE ON THE INFLAMMATORY RESPONSE IN CEREBROSPINAL-FLUID IN EXPERIMENTAL BACTERIAL-MENINGITIS | 10 | 19 |
| 2174 | 9 | 15 | 2674 2004 MICROCHEMICAL JOURNAL 77(1):1-7 Cardoso CE; Martins ROR; Aucelio RQ Evaluation of a spectrofluorimetric method for the selective determination of thalidomide in pharmaceutical tablets, urine and blood serum | 0 | 0 |
| 2175 | 3 | 18 | 508 1970 MIKROCHIMICA ACTA (3):530-& PISCHEK G; KAISER E; KOCH H THIN-LAYER CHROMATOGRAPHY OF THALIDOMIDE AND ITS HYDROLYSIS PRODUCTS | 6 | 12 |
| 2176 | 3 | 30 | 1154 1994 MIKROCHIMICA ACTA 117(1-2):75-85 AUCELIO RQ; CAMPIGLIA AD PHARMACEUTICAL FORMULATION ANALYSIS OF THALIDOMIDE BY SOLID-SURFACE ROOM-TEMPERATURE PHOSPHORIMETRY | 1 | 10 |
| 2177 | 11 | 35 | 1106 1993 MOLECULAR AND CELLULAR BIOCHEMISTRY 129(2):195-200 WEGLICKI WB; STAFFORD RE; DICKENS BF; MAK IT; CASSIDY MM; PHILLIPS TM INHIBITION OF TUMOR-NECROSIS-FACTOR-ALPHA BY THALIDOMIDE IN MAGNESIUM-DEFICIENCY | 4 | 9 |
| 2178 | 0 | 0 | 1213 1995 MOLECULAR BIOLOGY OF THE CELL 6:1195-1195 DESESSO JM; HARRIS SB; SCIALLI AR; GOERINGER GC EARLY MICROSCOPIC OBSERVATIONS OF THALIDOMIDE-INDUCED LIMB DEFECTS IN NEW-ZEALAND WHITE-RABBITS | 0 | 0 |
| 2179 | 0 | 0 | 1466 1998 MOLECULAR BIOLOGY OF THE CELL 9:200A-200A Wilson K; Lancaster T; Boyd M; Taylor LD Inhibition of cell-cell contacts in T lymphoblastic cells during exposure to thalidomide. | 0 | 0 |
| 2180 | 0 | 0 | 1580 1999 MOLECULAR BIOLOGY OF THE CELL 10:75A-75A Taylor LD; Settles B; Wilson K; Mack C Investigation of the inhibition of cell adhesion by the Anti-TNF-alpha agent thalidomide utilizing in vitro fluorescence-based assays. | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2181 | 0 | 0 | 1761 2000 MOLECULAR BIOLOGY OF THE CELL 11:112A-112A Stevenson AN; Odoms S; Ezell T; Valentine S; Taylor L Does thalidomide reduce inflammation by altering cell adhesion molecule expression and cell-cell contacts on CEM cells? | 0 | 0 |
| 2182 | 0 | 0 | 1762 2000 MOLECULAR BIOLOGY OF THE CELL 11:452A-452A Ezell TN; Odoms S; Davis M; Taylor L Human T leukemic cells exhibit biochemical changes consistent with apoptosis after treatment with tumor necrosis factor alpha and thalidomide. | 0 | 0 |
| 2183 | 0 | 0 | 1979 2001 MOLECULAR BIOLOGY OF THE CELL 12:23A-23A Ezell TN Apoptotic cell death induced by low doses of the tumor necrosis alpha inhibitor, thalidomide in human T leukemic cells | 0 | 0 |
| 2184 | 4 | 18 | 1214 1995 MOLECULAR MEDICINE 1(4):384-397 TRAMONTANA JM; UTAIPAT U; MOLLOY A; AKARASEWI P; BURROUGHS M; MAKONKAWKEYOON S; JOHNSON B; KLAUSNER JD; ROM W; KAPLAN G THALIDOMIDE TREATMENT REDUCES TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION AND ENHANCES WEIGHT-GAIN IN PATIENTS WITH PULMONARY TUBERCULOSIS | 60 | 130 |
| 2185 | 8 | 21 | 1286 1996 MOLECULAR MEDICINE 2(4):506-515 Corral LG; Muller GW; Moreira AL; Chen YX; Wu MD; Stirling D; Kaplan G Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity | 43 | 62 |
| 2186 | 5 | 5 | 1215 1995 MOLECULAR MEDICINE TODAY 1(5):210-210 STEWART A IS THALIDOMIDE A MUTAGEN | 0 | 0 |
| 2187 | 12 | 35 | 2536 2003 MOLECULAR PHARMACOLOGY 64(2):415-420 Drucker L; Uziel O; Tohami T; Shapiro H; Radnay J; Yarkoni S; Lahav M; Lishner M Thalidomide down-regulates transcript levels of GC-rich promoter genes in multiple myeloma | 0 | 1 |
| 2188 | 21 | 45 | 2675 2004 MOLECULES AND CELLS 17(2):210-216 Kim YS; Kim JS; Jung HC; Song IS The effects of thalidomide on the stimulation of NF-kappa B activity and TNF-alpha production by lipopolysaccharide in a human colonic epithelial cell line | 0 | 0 |
| 2189 | 15 | 46 | 440 1967 MONATSHEFTE FUR CHEMIE 98(3):702-& KOCH H; KOTLAN J; BRAUN H THALIDOMIDE ANALOGUES .2. | 10 | 13 |
| 2190 | 13 | 34 | 527 1971 MONATSHEFTE FUR CHEMIE 102(2):609-& KOCH H; KOTLAN J; FARKOUH E; LINDNER M THALIDOMIDE ANALOGUES .3. | 8 | 14 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2191 | 16 | 26 | 599 1974 MONATSHEFTE FUR CHEMIE 105(1):74-79 PISCHEK G; KAISER E; KOCH H THALIDOMIDE ANALOGS .5. INVESTIGATIONS OF METABOLISM OF THALIDOMIDE-LIKE COMPOUND K-2004 | 3 | 8 |
| 2192 | 0 | 32 | 402 1966 MONATSHEFTE FUR CHEMIE UND VERWANDTE TEILE ANDERER WISSENSCHAFTEN 97(6):1648-& KOCH H; KOTLAN J THALIDOMIDE ANALOGUES | 15 | 25 |
| 2193 | 4 | 12 | 730 1980 MONATSSCHRIFT KINDERHEILKUNDE 128(1):27-29 MILLER A; SCHMIDT CG; HORWITZ A; KOSENOW W COINCIDENCE OF A THALIDOMIDE-INDUCED MALFORMATION AND A LYMPHOMA OF HIGH MALIGNANCY | 1 | 1 |
| 2194 | 5 | 14 | 860 1984 MUSCLE & NERVE 7(5):362-368 SCHWAB BW; AREZZO JC; PALDINO AM; FLOHE L; MATTHIESSEN T; SPENCER PS RABBIT SURAL NERVE RESPONSES TO CHRONIC TREATMENT WITH THALIDOMIDE AND SUPIDIMIDE | 4 | 6 |
| 2195 | 19 | 41 | 929 1986 MUSCLE & NERVE 9(9):837-844 LAGUENY A; ROMMEL A; VIGNOLLY B; TAIEB A; VENDEAUDBUSQUET M; DOUTRE MS; JULIEN J THALIDOMIDE NEUROPATHY - AN ELECTROPHYSIOLOGIC STUDY | 21 | 28 |
| 2196 | 4 | 5 | 1763 2000 MUSCLE & NERVE 23(8):1301-1302 Rao DG; Kane NM; Oware A Thalidomide neuropathy: Role of F-wave monitoring | 5 | 5 |
| 2197 | 18 | 29 | 1980 2001 MUSCLE & NERVE 24(8):1050-1057 Molloy FM; Floeter MK; Syed NA; Sandbrink F; Culcea E; Steinberg SM; Dahut W; Pluda J; Kruger EA; Reed E; Figg WD Thalidomide neuropathy in patients treated for metastatic prostate cancer | 11 | 16 |
| 2198 | 16 | 59 | 1371 1997 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 396(1-2):45-64 Ashby J; Tinwell H; Callander RD; Kimber I; Clay P; Galloway SM; Hill RB; Greenwood SK; Gaulden ME; Ferguson MJ; Vogel E; Nivard M; Parry JM; Williamson J Thalidomide: lack of mutagenic activity across phyla and genetic endpoints | 12 | 14 |
| 2199 | 30 | 79 | 1581 1999 MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 425(1):153-167 Zhu XY; Zhang YP; Klopman G; Rosenkranz HS Thalidomide and metabolites: indications of the absence of 'genotoxic' carcinogenic potentials | 3 | 3 |
| 2200 | 102 | 148 | 1764 2000 NATIONAL MEDICAL JOURNAL OF INDIA 13(3):132-141 Grover JK; Vats V; Gopalakrishna R; Ramam M Thalidomide: A re-look | 2 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2201 | 0 | 7 | 247 1963 NATURE 198(488):1068-& BONEY AD ABNORMAL GROWTH OF SPORELINGS OF A MARINE RED ALGA INDUCED BY THALIDOMIDE | 3 | 10 |
| 2202 | 1 | 2 | 248 1963 NATURE 199(489):1204-& DEBOCK CA; PETERS A EFFECT OF THALIDOMIDE ON DEVELOPMENT OF CHICK EMBRYO | 7 | 11 |
| 2203 | 4 | 8 | 249 1963 NATURE 200(491):1016-& ROE FJC; MITCHLEY BC THALIDOMIDE AND NEOPLASIA | 8 | 13 |
| 2204 | 1 | 1 | 292 1964 NATURE 201(492):940-& GIACOMELLO G; QUAGLIA G; MALATEST.P ACTION OF THALIDOMIDE ON RADICAL MERISTEMS OF ALLIUM CEPA | 4 | 9 |
| 2205 | 6 | 12 | 293 1964 NATURE 201(492):1125-& FABRO S; SCHUMACHER H; SMITH RL; WILLIAMS RT IDENTIFICATION OF THALIDOMIDE IN RABBIT BLASTOCYSTS | 11 | 21 |
| 2206 | 0 | 14 | 294 1964 NATURE 202(493):1080-& VASILESCU V; CONSTANTINESCU M; DIMOFTAC.C; CIURES A CYTOSPECTROPHOTOMETRIC INVESTIGATION OF ACTION OF THALIDOMIDE ON NUCLEUS OF LYMPHOCYTE | 0 | 6 |
| 2207 | 5 | 14 | 295 1964 NATURE 204(496):939-& TATA JR THALIDOMIDE + INDUCED AMPHIBIAN METAMORPHOSIS | 2 | 3 |
| 2208 | 3 | 4 | 345 1965 NATURE 205(4971):621-& LORKIEWI.Z; DUDEK M; ZIEMIECK.J STIMULATION OF TRANSFORMATION BY THALIDOMIDE | 0 | 2 |
| 2209 | 4 | 5 | 346 1965 NATURE 205(4977):1241-& PARUPS EV; HOFFMAN I ABSENCE OF GROWTH EFFECTS OF THALIDOMIDE ON HIGHER PLANTS | 0 | 6 |
| 2210 | 4 | 6 | 347 1965 NATURE 208(5016):1208-& FABRO S; SMITH RL; WILLIAMS RT THALIDOMIDE AS A POSSIBLE BIOLOGICAL ACYLATING AGENT | 18 | 30 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2211 | 6 | 13 | 403 1966 NATURE 210(5039):958-& HENDRICK.AG; AXELROD LR; CLAYBORN LD THALIDOMIDE SYNDROME IN BABOONS | 0 | 23 |
| 2212 | 2 | 12 | 404 1966 NATURE 211(5055):1308-& FIELD EO; GIBBS JE; TUCKER DF; HELLMANN K EFFECT OF THALIDOMIDE ON GRAFT VERSUS HOST REACTION | 41 | 48 |
| 2213 | 0 | 3 | 441 1967 NATURE 214(5092):1018-& LUTWAKMA.C; SCHMID K; KEBERLE H THALIDOMIDE IN RABBIT SEMEN | 0 | 40 |
| 2214 | 2 | 6 | 442 1967 NATURE 215(5098):296-& FABRO S; SMITH RL; WILLIAMS RT TOXICITY AND TERATOGENICITY OF OPTICAL ISOMERS OF THALIDOMIDE | 30 | 58 |
| 2215 | 2 | 7 | 528 1971 NATURE 232(5313):634-& LASH JW; SAXEN L EFFECT OF THALIDOMIDE ON HUMAN EMBRYONIC TISSUES | 7 | 18 |
| 2216 | 0 | 0 | 556 1972 NATURE 240(5379):246-& [Anon] INSURING FOR THALIDOMIDE | 0 | 0 |
| 2217 | 0 | 0 | 977 1988 NATURE 336(6195):101-101 EWING T THALIDOMIDE SCIENTIST GUILTY OF FRAUD SAYS COMMITTEE | 0 | 2 |
| 2218 | 4 | 11 | 1216 1995 NATURE 375(6531):453-453 ASHBY J; TINWELL H IS THALIDOMIDE MUTAGENIC | 7 | 11 |
| 2219 | 5 | 9 | 1372 1997 NATURE 385(6614):303-304 Wnendt S; Zwingenberger K Thalidomide's chirality | 9 | 16 |
| 2220 | 2 | 5 | 1373 1997 NATURE 389(6647):118-118 Ashby J Thalidomide is not a mutagen | 3 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2221 | 3 | 9 | 1467 1998 NATURE 396(6709):322-323 Tabin CJ A developmental model for thalidomide defects | 9 | 20 |
| 2222 | 4 | 11 | 1582 1999 NATURE 400(6743):419-420 Neubert R; Merker HT; Neubert D Developmental model for thalidomide action | 3 | 4 |
| 2223 | 2 | 12 | 1583 1999 NATURE 400(6743):420-420 Tabin CJ Developmental model for thalidomide action - Reply | 0 | 0 |
| 2224 | 0 | 1 | 1981 2001 NATURE 410(6827):411-412 Dormandy T Dark remedy: The impact of thalidomide and its revival as a vital medicine | 0 | 0 |
| 2225 | 0 | 0 | 1374 1997 NATURE BIOTECHNOLOGY 15(11):1238-1239 Brower V Thalidomide checks might have saved Redux | 0 | 1 |
| 2226 | 0 | 0 | 1375 1997 NATURE BIOTECHNOLOGY 15(12):1238-1239 Brower V Thalidomide checks might have saved Redux | 0 | 0 |
| 2227 | 0 | 0 | 1468 1998 NATURE BIOTECHNOLOGY 16(8):695-695 [Anon] The problem with thalidomide's new incarnation | 0 | 0 |
| 2228 | 0 | 0 | 1217 1995 NATURE MEDICINE 1(12):1230-1230 GERSHON D FINDING NEW USES FOR THALIDOMIDE | 3 | 5 |
| 2229 | 4 | 5 | 1287 1996 NATURE MEDICINE 2(2):132-132 Crawford CL Thalidomide neuropathy | 1 | 1 |
| 2230 | 0 | 0 | 1376 1997 NATURE MEDICINE 3(1):8-8 Cimons M Thalidomide resurfaces for FDA consideration | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2231 | 7 | 11 | 1584 1999 NATURE MEDICINE 5(5):489-490 Hales BF Thalidomide on the comeback trail | 29 | 31 |
| 2232 | 13 | 25 | 1585 1999 NATURE MEDICINE 5(5):582-585 Parman T; Wiley MJ; Wells PG Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity | 65 | 110 |
| 2233 | 1 | 3 | 1586 1999 NATURE MEDICINE 5(8):853-853 Guenzler V Mechanisms of thalidomide teratogenicity | 2 | 3 |
| 2234 | 44 | 57 | 2676 2004 NATURE REVIEWS CANCER 4(4):314-322 Bartlett JB; Dredge K; Dalgleish AG Timeline - The evolution of thalidomide and its IMiD derivatives as anticancer agents | 1 | 1 |
| 2235 | 2 | 9 | 405 1966 NATURWISSENSCHAFTEN 53(11):275-& NATARAJA.AT; NILSSON R STUDIES ON CYTOLOGICAL EFFECTS OF THALIDOMIDE AND ITS HYDROLYTIC PRODUCTS | 0 | 7 |
| 2236 | 4 | 10 | 785 1982 NATURWISSENSCHAFTEN 69(4):191-192 KOCHERBECKER U; KOCHER W; OCKENFELS H TERATOGENIC ACTIVITY OF A HYDROLYTIC THALIDOMIDE METABOLITE IN MICE | 3 | 4 |
| 2237 | 0 | 0 | 509 1970 NAUNYN-SCHMIEDEBERGS ARCHIV FUR PHARMAKOLOGIE 266(4-5):408-& NEUBERT D; KOHLER E HYPOTHETICAL EXPLANATION OF EMBRYTOXIC ACTION OF THALIDOMIDE | 2 | 3 |
| 2238 | 0 | 0 | 1377 1997 NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 355(4):545-545 Stahl W; Nicolai S; Sies H Stimulation of gap junctional communication by thalidomide and thalidomide analogs in human skin fibroblasts | 0 | 0 |
| 2239 | 8 | 29 | 1378 1997 NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 356(5):529-535 Dunzendorfer S; Schratzberger P; Reinisch N; Kahler CM; Wiedermann CJ Effects of thalidomide on neutrophil respiratory burst, chemotaxis, and transmigration of cytokine-and endotoxin-activated endothelium | 17 | 23 |
| 2240 | 0 | 0 | 1469 1998 NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 357(4):R119-R119 Thiel R; Klug S Adhesion receptors on rat limb bud cells after treatment with a thalidomide derivative | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2241 | 0 | 0 | 1470 1998 NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 358(1):R479-R479 Bignone IM; Papale RM; Seoane M; Bazerque PM Thalidomide - New trends for therapeutical use | 0 | 0 |
| 2242 | 3 | 23 | 1155 1994 NEPHRON 67(3):270-273 SILVA SRB; VIANA PCF; LUGON NV; HOETTE M; RUZANY F; LUGON JR THALIDOMIDE FOR THE TREATMENT OF UREMIC PRURITUS - A CROSSOVER RANDOMIZED DOUBLE-BLIND TRIAL | 20 | 43 |
| 2243 | 13 | 21 | 1982 2001 NETHERLANDS JOURNAL OF MEDICINE 59(2):45-49 van de Poel MHW; Pasman PC; Schouten HC The use of thalidomide in chronic refractory graft versus host disease | 1 | 3 |
| 2244 | 1 | 7 | 1050 1991 NEURO-OPHTHALMOLOGY 11(1):29-32 HUYGEN PLM; VANRIJN PM; VERHAGEN WIM; CREMERS CWRJ; THEUNISSEN EJJM SUBCORTICAL OPTOKINETIC RESPONSE IN A CASE OF THALIDOMIDE FETOPATHY | 0 | 1 |
| 2245 | 0 | 0 | 2269 2002 NEUROBIOLOGY OF AGING 23(1):S93-S93 Burke W; Bohac D; Cotter R; Zheng JL; Potter J; Gendelman H A 26 week double blind, placebo-controlled study of the efficacy of thalidomide in the treatment of Alzheimer's disease | 0 | 0 |
| 2246 | 0 | 0 | 1218 1995 NEUROLOGY 45(4):A168-A168 CLAVELOU P; COLAMARINO R; DINCAN M; DEFFOND D; TOURNILHAC M; SOUTEYRAND P THALIDOMIDE-RELATED NEUROPATHY - A PROSPECTIVE, CLINICAL, ELECTROMYOGRAPHIC TRIAL | 1 | 1 |
| 2247 | 0 | 0 | 1288 1996 NEUROLOGY 46(2):3015-3015 Openshaw H; Slatkin NE; Parker P Thalidomide neuropathy in bone marrow transplantation | 0 | 0 |
| 2248 | 0 | 0 | 1289 1996 NEUROLOGY 46(2):27003-27003 Chaudhry V; Cornblath D; Corse A; Freimer M; SimmonsOBrien E; Vogelsang G Thalidomide-induced neuropathy: Clinical and electrophysiological features | 0 | 0 |
| 2249 | 0 | 0 | 1471 1998 NEUROLOGY 50(4):A208-A208 Poncelet AN; Maurer TA; Wu ZQ; Ng J; Badger J; Berger TG Peripheral neuropathy in HIV-infected patients with prurigo nodularis treated with thalidomide: Clinical and electrophysiologic features | 0 | 0 |
| 2250 | 0 | 0 | 1472 1998 NEUROLOGY 50(4):A383-A384 Frennier JM; Abrey LE; Haimovitz-Friedman A; McLoughlin M; Rosenfeld MR Does thalidomide have a role in glioma angiogenesis? | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2251 | 0 | 0 | 1587 1999 NEUROLOGY 52(6):A424-A425 Li HW; Zhu LX; Karpati G; Nalbantoglu J Effect of thalidomide on growth of experimental intracerebral gliomas | 0 | 0 |
| 2252 | 0 | 0 | 1765 2000 NEUROLOGY 54(7):A12-A13 Gupta A; Cohen BH; Ruggieri P; Packer RJ; Phillips P A phase I study of thalidomide for the treatment of plexiform neurofibroma in patients with neurofibromatosis 1 (NF1) | 0 | 0 |
| 2253 | 0 | 0 | 1983 2001 NEUROLOGY 56(8):A208-A209 Khella SL; Souayah N; AMDATS Study Grp Thalidomide polyneuropathy: A prospective double-masked placebo-controlled study in an elderly population with age-related macular degeneration | 0 | 0 |
| 2254 | 21 | 29 | 2270 2002 NEUROLOGY 59(12):1872-1875 Chaudhry V; Cornblath DR; Corse A; Freimer M; Simmons-O'Brien E; Vogelsang G Thalidomide-induced neuropathy | 6 | 7 |
| 2255 | 7 | 10 | 2537 2003 NEUROLOGY 60(1):130-132 Gupta A; Cohen BH; Ruggieri P; Packer RJ; Phillips PC Phase I study of thalidomide for the treatment of plexiform neurofibroma in neurofibromatosis 1 | 1 | 2 |
| 2256 | 4 | 7 | 2538 2003 NEUROLOGY 60(5):877-878 Giannini F; Volpi N; Rossi S; Passero S; Fimiani M; Cerase A Thalidomide-induced neuropathy: a ganglionopathy? | 3 | 3 |
| 2257 | 15 | 16 | 2677 2004 NEUROLOGY 62(12):2158-2159 Apfel SC; Zochodne DW Thalidomide neuropathy - Too much or too long? | 0 | 0 |
| 2258 | 8 | 10 | 2678 2004 NEUROLOGY 62(12):2288-2290 Briani C; Zara G; Rondinone R; Della Libera S; Ermani M; Ruggero S; Ghirardello A; Zampieri S; Doria A Thalidomide neurotoxicity - Prospective study in patients with lupus erythematosus | 1 | 1 |
| 2259 | 8 | 10 | 2679 2004 NEUROLOGY 62(12):2291-2293 Cavaletti G; Beronio A; Reni L; Ghiglione E; Schenone A; Briani C; Zara G; Cocito D; Isoardo G; Ciaramitaro P; Plasmati R; Pastorelli F; Frigo M; Piatti M; Carpo M Thalidomide sensory neurotoxicity - A clinical and neurophysiologic study | 1 | 1 |
| 2260 | 0 | 0 | 1290 1996 NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY 22(5):456-456 Chakrabarty A; Bridges LR Cerebral malformation in a patient with thalidomide related phocomelia | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2261 | 5 | 25 | 1291 1996 NEUROREPORT 7(12):1881-1886 Kanbayashi T; Nishino S; Tafti M; Hishikawa Y; Dement WC; Mignot E Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy | 1 | 6 |
| 2262 | 4 | 29 | 1379 1997 NEUROSCIENCE LETTERS 234(2-3):123-126 Boireau A; Bordier F; Dubedat P; Peny C; Imperato A Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice | 0 | 9 |
| 2263 | 1 | 26 | 1984 2001 NEUROTOXICOLOGY AND TERATOLOGY 23(3):255-264 Vorhees CV; Weisenburger WP; Minck DR Neurobehavioral teratogenic effects of thalidomide in rats | 1 | 3 |
| 2264 | 4 | 10 | 166 1962 NEW ENGLAND JOURNAL OF MEDICINE 266(24):1268-& COHEN S THALIDOMIDE POLYNEUROPATHY | 8 | 10 |
| 2265 | 22 | 67 | 167 1962 NEW ENGLAND JOURNAL OF MEDICINE 267(23):1179-& MAHON WA; MITCHELL ML; KATZENSTEIN M; STEINKE J; RABEN MS SAGA OF THALIDOMIDE - NEUROPATHY TO EMBRYOPATHY, WITH CASE REPORTS OF CONGENITAL ANOMALIES | 0 | 35 |
| 2266 | 0 | 168 1962 NEW ENGLAND JOURNAL OF MEDICINE 267(23):1184-1192 MELLIN GW; KATZENSTEIN M THE SAGA OF THALIDOMIDE. NEUROPATHY TO EMBRYOPATHY, WITH CASE REPORTS OF CONGENITAL ANOMALIES | 83 | 169 | |
| 2267 | 34 | 65 | 169 1962 NEW ENGLAND JOURNAL OF MEDICINE 267(24):1238-1244 MELLIN GW; KATZENSTEIN M THE SAGA OF THALIDOMIDE. NEUROPATHY TO EMBRYOPATHY, WITH CASE REPORTS OF CONGENITAL ANOMALIES | 64 | 109 |
| 2268 | 0 | 0 | 170 1962 NEW ENGLAND JOURNAL OF MEDICINE 267(25):1320-& WHITEHILL LA THALIDOMIDE AND PHOCOMELIA | 0 | 0 |
| 2269 | 2 | 2 | 250 1963 NEW ENGLAND JOURNAL OF MEDICINE 268(11):624-& HUSSEY LM; WEINBERG M ACTION OF THALIDOMIDE | 1 | 1 |
| 2270 | 5 | 10 | 251 1963 NEW ENGLAND JOURNAL OF MEDICINE 269(2):92-& TAUSSIG HB EVILS OF CAMOUFLAGE AS ILLUSTRATED BY THALIDOMIDE | 1 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2271 | 3 | 4 | 296 1964 NEW ENGLAND JOURNAL OF MEDICINE 271(9):441-& INGALLS TH; ZAPPASODI P; CURLEY FJ THALIDOMIDE EMBRYOPATHY IN HYPRID RABBITS | 6 | 13 |
| 2272 | 0 | 1 | 297 1964 NEW ENGLAND JOURNAL OF MEDICINE 271(18):963-& WHITEHILL LA; INGALLS TH THALIDOMIDE EMBRYOPATHY | 0 | 0 |
| 2273 | 0 | 2 | 529 1971 NEW ENGLAND JOURNAL OF MEDICINE 284(9):481-& CURRAN WJ THALIDOMIDE TRAGEDY IN GERMANY - END OF A HISTORIC MEDICOLEGAL TRIAL | 1 | 4 |
| 2274 | 9 | 21 | 1070 1992 NEW ENGLAND JOURNAL OF MEDICINE 326(16):1055-1058 VOGELSANG GB; FARMER ER; HESS AD; ALTAMONTE V; BESCHORNER WE; JABS DA; CORIO RL; LEVIN LS; COLVIN OM; WINGARD JR; SANTOS GW THALIDOMIDE FOR THE TREATMENT OF CHRONIC GRAFT-VERSUS-HOST DISEASE | 166 | 253 |
| 2275 | 6 | 9 | 1071 1992 NEW ENGLAND JOURNAL OF MEDICINE 327(3):208-209 RYAN J; COLMAN J; PEDERSEN J; BENSON E THALIDOMIDE TO TREAT ESOPHAGEAL ULCER IN AIDS | 24 | 33 |
| 2276 | 2 | 2 | 1072 1992 NEW ENGLAND JOURNAL OF MEDICINE 327(10):735-735 VOGELSANG GB THALIDOMIDE NEUROPATHY - REPLY | 2 | 2 |
| 2277 | 5 | 5 | 1073 1992 NEW ENGLAND JOURNAL OF MEDICINE 327(10):735-735 CRAWFORD CL THALIDOMIDE NEUROPATHY | 5 | 6 |
| 2278 | 24 | 44 | 1380 1997 NEW ENGLAND JOURNAL OF MEDICINE 336(21):1487-1493 Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection | 119 | 191 |
| 2279 | 3 | 3 | 1381 1997 NEW ENGLAND JOURNAL OF MEDICINE 337(15):1086-1087 Birnkrant D Thalidomide for aphthous ulcers in HIV infection | 1 | 2 |
| 2280 | 0 | 1 | 1382 1997 NEW ENGLAND JOURNAL OF MEDICINE 337(15):1087-1087 Jacobson JM; Greenspan JS; Spritzler J Thalidomide for aphthous ulcers in HIV infection - Reply | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2281 | 10 | 37 | 1588 1999 NEW ENGLAND JOURNAL OF MEDICINE 341(21):1565-1571 Singhal S; Mehta J; Desikan R; Ayers D; Roberson P; Eddlemon P; Munshi N; Anaissie E; Wilson C; Dhodapkar M; Zeldis J; Barlogie B; Siegel D; Crowley J Antitumor activity of thalidomide in refractory multiple myeloma. | 284 | 548 |
| 2282 | 8 | 17 | 1589 1999 NEW ENGLAND JOURNAL OF MEDICINE 341(21):1606-1609 Raje N; Anderson K Thalidomide - A revival story. | 48 | 87 |
| 2283 | 1 | 1 | 1766 2000 NEW ENGLAND JOURNAL OF MEDICINE 342(5):364-364 Singhal S Antitumor activity of thalidomide in refractory multiple myeloma (vol 341, pg 1565, 1999) | 7 | 15 |
| 2284 | 1 | 1 | 1767 2000 NEW ENGLAND JOURNAL OF MEDICINE 342(13):975-975 Kishi Y; Oki Y; Machida U Thalidomide in multiple myeloma | 3 | 5 |
| 2285 | 1 | 4 | 1768 2000 NEW ENGLAND JOURNAL OF MEDICINE 342(13):975-976 Barlogie B Thalidomide in multiple myeloma - Reply | 0 | 0 |
| 2286 | 4 | 6 | 1769 2000 NEW ENGLAND JOURNAL OF MEDICINE 343(13):972-973 Rajkumar SV; Gertz MA; Witzig TE Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma. | 23 | 33 |
| 2287 | 3 | 4 | 1985 2001 NEW ENGLAND JOURNAL OF MEDICINE 344(25):1951-1952 Osman K; Comenzo R; Rajkumar SV Deep venous thrombosis and thalidomide therapy for multiple myeloma. | 44 | 57 |
| 2288 | 3 | 3 | 1986 2001 NEW ENGLAND JOURNAL OF MEDICINE 345(16):1214-1215 Kudva GC; Collins BT; Dunphy FR Thalidomide for malignant melanoma. | 1 | 2 |
| 2289 | 2 | 3 | 2539 2003 NEW ENGLAND JOURNAL OF MEDICINE 348(18):1821-1822 Morgan AE; Smith WK; Levenson JL Reversible dementia due to thalidomide therapy for multiple myeloma | 1 | 1 |
| 2290 | 0 | 0 | 406 1966 NEW REPUBLIC 154(2):12-14 RIDGEWAY J MORE ABOUT THALIDOMIDE | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2291 | 0 | 1 | 407 1966 NEW REPUBLIC 154(8):36-37 VANAALST FL THALIDOMIDE | 0 | 0 |
| 2292 | 0 | 1 | 708 1979 NEW REPUBLIC 180(16):30-32 MINTZ M SUFFER THE CHILDREN - STORY OF THALIDOMIDE BY THE INSIGHT TEAM OF THE SUNDAY-TIMES OF LONDON | 0 | 0 |
| 2293 | 0 | 0 | 678 1978 NEW SCIENTIST 77(1088):277-279 CRAWFORD C FRESH CONCERN OVER THALIDOMIDE | 0 | 0 |
| 2294 | 0 | 0 | 827 1983 NEW SCIENTIST 99(1371):457-457 MACKENZIE D SECRET TESTS SAY THALIDOMIDE IS MUTAGENIC | 0 | 0 |
| 2295 | 0 | 1 | 828 1983 NEW SCIENTIST 100(1378):49-49 FLOHE L THALIDOMIDE | 0 | 0 |
| 2296 | 0 | 0 | 1107 1993 NEW SCIENTIST 137(1862):6-6 DAYTON L THALIDOMIDE HERO FOUND GUILTY OF SCIENTIFIC FRAUD | 0 | 0 |
| 2297 | 0 | 0 | 510 1970 NEW SOCIETY 16(417):543-543 WATSON P THWARTING THALIDOMIDE THREAT | 0 | 0 |
| 2298 | 0 | 0 | 903 1985 NEW SOCIETY 74(1196):369-371 CAUDREY A THALIDOMIDE GENERATION | 0 | 0 |
| 2299 | 0 | 1 | 1987 2001 NEW YORK REVIEW OF BOOKS 48(8):12-15 Horton R Dark remedy: The impact of thalidomide and its revival as a vital medicine | 0 | 0 |
| 2300 | 0 | 1 | 709 1979 NEW YORK TIMES BOOK REVIEW 84(6):11-11 POWERS T SUFFER THE CHILDREN - STORY OF THALIDOMIDE - "SUNDAY-TIMES-OF-LONDON-INSIGHT-TEAM | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2301 | 1 | 5 | 786 1982 NOUVELLE PRESSE MEDICALE 11(14):1080-1081 HAMZA M; CHAFFAI M; BENAYED H TREATMENT OF BEHCETS-DISEASE WITH THALIDOMIDE | 9 | 15 |
| 2302 | 0 | 0 | 654 1977 OBSIDIAN-BLACK LITERATURE IN REVIEW 3(1):53-53 KOMUNYAKAA Y 'THALIDOMIDE' | 0 | 0 |
| 2303 | 4 | 11 | 2271 2002 OBSTETRICS AND GYNECOLOGY 99(1):125-128 Ances BM New concerns about thalidomide | 1 | 3 |
| 2304 | 3 | 31 | 2540 2003 ONCOLOGIST 8:39-45 Hussein MA Modifications to therapy for multiple myeloma: Pegylated liposomal doxorubicin in combination with vincristine, reduced-dose dexamethasone, and thalidomide | 0 | 1 |
| 2305 | 15 | 44 | 2541 2003 ONCOLOGY 65(3):242-249 Hsu C; Chen CN; Chen LT; Wu CY; Yang PM; Lai MY; Lee PH; Cheng AL Low-dose thalidomide treatment for advanced hepatocellular carcinoma | 1 | 3 |
| 2306 | 14 | 27 | 2680 2004 ONCOLOGY REPORTS 11(1):93-95 Morabito A; Fanelli M; Carillio G; Gattuso D; Sarmiento R; Gasparini G Thalidomide prolongs disease stabilization after conventional therapy in patients with recurrent glioblastoma | 0 | 0 |
| 2307 | 0 | 0 | 1590 1999 ONCOLOGY-NEW YORK 13(5):744-744 [Anon] Thalidomide shows promising results in patients with multiple myeloma | 0 | 0 |
| 2308 | 0 | 0 | 1770 2000 ONCOLOGY-NEW YORK 14(3):452-452 [Anon] Substantial activity of thalidomide in multiple myeloma, study shows | 0 | 0 |
| 2309 | 0 | 0 | 1771 2000 ONCOLOGY-NEW YORK 14(4):479-479 [Anon] Thalidomide active in advanced multiple myeloma | 0 | 0 |
| 2310 | 0 | 0 | 1772 2000 ONCOLOGY-NEW YORK 14(7):1081-1081 [Anon] Expanded data on thalidomide in advanced myeloma | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2311 | 0 | 0 | 1773 2000 ONCOLOGY-NEW YORK 14(12):9-10 Rajkumar SV Thalidomide in hematologic and oncologic disease - Proceedings of an Investigators' Meeting - May 20, 2000, New Orleans - Introduction | 2 | 2 |
| 2312 | 14 | 57 | 1774 2000 ONCOLOGY-NEW YORK 14(12):11-16 Rajkumar SV Thalidomide in multiple myeloma | 9 | 17 |
| 2313 | 4 | 12 | 1775 2000 ONCOLOGY-NEW YORK 14(12):17-20 Eisen TG Thalidomide in solid tumors: The London experience | 11 | 15 |
| 2314 | 7 | 16 | 1776 2000 ONCOLOGY-NEW YORK 14(12):25-28 Hwu WJ New approaches in the treatment of metastatic melanoma: Thalidomide and temozolomide | 6 | 14 |
| 2315 | 2 | 8 | 1777 2000 ONCOLOGY-NEW YORK 14(12):29-32 Govindarajan R Irinotecan and thalidomide in metastatic colorectal cancer | 7 | 12 |
| 2316 | 7 | 18 | 1778 2000 ONCOLOGY-NEW YORK 14(12):33-36 Amato R Thalidomide for recurrent renal-cell cancer in a 40-year-old man | 2 | 2 |
| 2317 | 0 | 0 | 1988 2001 ONCOLOGY-NEW YORK 15(3):301-301 [Anon] Thalidomide analogs active against multiple myeloma | 0 | 0 |
| 2318 | 0 | 0 | 1989 2001 ONCOLOGY-NEW YORK 15(4):493-+ [Anon] Thalidomide studied in a variety of cancers and metabolic disorders | 0 | 0 |
| 2319 | 34 | 70 | 1990 2001 ONCOLOGY-NEW YORK 15(7):867-874 Rajkumar SV Current status of thalidomide in the treatment of cancer | 9 | 14 |
| 2320 | 4 | 8 | 1991 2001 ONCOLOGY-NEW YORK 15(7):877-878 Govindarajan R Current status of thalidomide in the treatment of cancer - The Rajkumar article reviewed | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2321 | 2 | 8 | 1992 2001 ONCOLOGY-NEW YORK 15(7):878-879 Hwu WJ Current status of thalidomide in the treatment of cancer - The Rajkumar article reviewed | 0 | 0 |
| 2322 | 1 | 1 | 2272 2002 ONCOLOGY-NEW YORK 16(1):21-22 Kurstin R Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease | 1 | 1 |
| 2323 | 19 | 28 | 2273 2002 ONCOLOGY-NEW YORK 16(1):22-24 Richardson P; Anderson K Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease - Drs. Paul Richardson and Kenneth Anderson respond | 0 | 0 |
| 2324 | 1 | 4 | 2274 2002 ONCOLOGY-NEW YORK 16(3):276-+ Phuphanich S Recurrent multicentric glioblastoma multiforme responds to thalidomide and chemotherapy | 0 | 0 |
| 2325 | 4 | 17 | 2275 2002 ONCOLOGY-NEW YORK 16(4):23-26 Govindarajan R Irinoteean/Thalidomide in metastatic colorectal cancer | 4 | 5 |
| 2326 | 3 | 5 | 2276 2002 ONCOLOGY-NEW YORK 16(9):1146-+ Leibowitz R; Tucker SJ PSA response to thalidomide in patients with advanced prostate cancer | 0 | 0 |
| 2327 | 14 | 24 | 2681 2004 ONKOLOGIE 27(2):150-154 Steurer M; Spizzo G; Mitterer M; Gastl G Low-dose thalidomide for multiple myeloma: Interim analysis of a compassionate use program | 0 | 0 |
| 2328 | 1 | 10 | 627 1976 OPHTHALMIC RESEARCH 8(2):146-151 LASZCZYK WA; NACIAZEKWIENIAWSKA A; WITOWSKAVEIT M CHANGES IN VISUAL-SYSTEM OF RABBIT FETUSES AFTER THALIDOMIDE ADMINISTRATION | 0 | 0 |
| 2329 | 24 | 55 | 1993 2001 OPHTHALMIC RESEARCH 33(5):256-263 Baatz H; Tonessen B; Prada J; Pleyer U Thalidomide inhibits leukocyte-endothelium interaction in endotoxin-induced uveitis | 1 | 4 |
| 2330 | 6 | 15 | 1994 2001 OPHTHALMOLOGICA 215(1):70-73 Parentin F; Da Pozzo S; Lepore L; Perissutti P Thalidomide effectiveness for bilateral chronic idiopathic anterior uveitis in a three-year-old child | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2331 | 7 | 40 | 1995 2001 OPHTHALMOLOGICA 215(4):284-289 Kaven C; Spraul CW; Zavazava N; Lang GK; Lang GE Thalidomide and prednisolone inhibit growth factor-induced human retinal pigment epithelium cell proliferation in vitro | 2 | 7 |
| 2332 | 53 | 61 | 2277 2002 ORAL ONCOLOGY 38(6):527-531 Porter SR; Jorge J Thalidomide: a role in oral oncology? | 0 | 1 |
| 2333 | 10 | 11 | 948 1987 ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS 64(3):289-292 EISENBUD L; HOROWITZ I; KAY B RECURRENT APHTHOUS STOMATITIS OF THE BEHCETS TYPE - SUCCESSFUL TREATMENT WITH THALIDOMIDE | 7 | 18 |
| 2334 | 12 | 20 | 1383 1997 ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS 84(4):362-364 Elad S; Galili D; Garfunkel AA; Or R Thalidomide-induced perioral neuropathy | 2 | 3 |
| 2335 | 45 | 67 | 2542 2003 ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS 95(5):576-585 Hegarty A; Hodgson T; Porter S Thalidomide for the treatment of recalcitrant oral Crohn's disease and orofacial granulomatosis | 1 | 2 |
| 2336 | 19 | 39 | 1591 1999 ORGANIC LETTERS 1(10):1571-1573 Takeuchi Y; Shiragami T; Kimura K; Suzuki E; Shibata N (R)- and (S)-3-fluorothalidomides: Isosteric analogues of thalidomide | 3 | 13 |
| 2337 | 20 | 25 | 2543 2003 ORGANIC LETTERS 5(16):2865-2867 Capitosti SM; Hansen TP; Brown ML Facile synthesis of an azido-labeled thalidomide analogue | 0 | 1 |
| 2338 | 4 | 13 | 1592 1999 ORGANIC PROCESS RESEARCH & DEVELOPMENT 3(2):139-140 Muller GW; Konnecke WE; Smith AM; Khetani VD A concise two-step synthesis of thalidomide | 5 | 12 |
| 2339 | 10 | 55 | 1473 1998 PAIN 74(1):83-91 Sommer C; Marziniak M; Myers RR The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve | 5 | 54 |
| 2340 | 8 | 38 | 1779 2000 PAIN 88(3):267-275 George A; Marziniak M; Schafers M; Toyka KV; Sommer C Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin | 4 | 20 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2341 | 2 | 4 | 1474 1998 PALLIATIVE MEDICINE 12(3):208-209 Deaner P Thalidomide for distressing night sweats in advanced malignant disease | 12 | 13 |
| 2342 | 1 | 2 | 1780 2000 PALLIATIVE MEDICINE 14(1):77-78 Calder K; Bruera E Thalidomide for night sweats in patients with advanced cancer | 6 | 7 |
| 2343 | 2 | 4 | 1781 2000 PALLIATIVE MEDICINE 14(5):429-431 Deaner PB The use of thalidomide in the management of severe sweating in patients with advanced malignancy: trial report | 0 | 1 |
| 2344 | 0 | 0 | 1156 1994 PANMINERVA MEDICA 36(1):1-4 VOSGERAU JCB AUTOIMMUNITY IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND THE USE OF THALIDOMIDE | 3 | 3 |
| 2345 | 0 | 0 | 1157 1994 PANMINERVA MEDICA 36(1):44-47 VOSGERAU JCB ATYPICAL HERPES SIMPLE - A SIGN OF TOXOPLASMOSIS ACTIVITY IN AIDS PATIENTS AND THE USE OF THALIDOMIDE | 0 | 1 |
| 2346 | 0 | 0 | 348 1965 PATHOLOGIE BIOLOGIE 13(11-1):709-& ROUX C; CAHEN R; DUPUIS R MALFORMATIONS VISCERALES PROVOQUEES PAR LE THALIDOMIDE CHEZ LE LAPIN | 0 | 0 |
| 2347 | 0 | 0 | 349 1965 PATHOLOGIE BIOLOGIE 13(23-2):1241-& CHAMPYHA.S LE GLUTARIMIDE ET LACTIVITE DE LA THALIDOMIDE . ETUDE SPECTRALE ETENDUE JUSQUE VERS 2050A | 0 | 0 |
| 2348 | 4 | 18 | 759 1981 PATHOLOGIE BIOLOGIE 29(10):601-604 FAURE M; LEJEUNE JP; GAUCHERAND M; THIVOLET J PMN LEUKOCYTES CHEMOTAXIS - INHIBITION BY THALIDOMIDE | 6 | 9 |
| 2349 | 11 | 41 | 2682 2004 PATHOLOGY INTERNATIONAL 54(5):285-294 Du WL; Hattori Y; Hashiguchi A; Kondoh K; Hozumi N; Ikeda Y; Sakamoto M; Hata J; Yamada T Tumor angiogenesis in the bone marrow of multiple myeloma patients and its alteration by thalidomide treatment | 0 | 0 |
| 2350 | 11 | 22 | 2544 2003 PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS 33:15-18 Rodeghiero F; Elice F Thalidomide and thrombosis | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2351 | 0 | 0 | 1108 1993 PEDIATRIC DERMATOLOGY 10(3):283-285 MENNI S; IMONDI D; BRANCALEONE W; CROCI S RECURRENT GIANT APHTHOUS ULCERS IN A CHILD - PROTRACTED TREATMENT WITH THALIDOMIDE | 5 | 10 |
| 2352 | 9 | 16 | 1996 2001 PEDIATRIC DERMATOLOGY 18(2):143-145 Brik R; Shamali H; Bergman R Successful thalidomide treatment of severe infantile Behcet disease | 1 | 1 |
| 2353 | 10 | 14 | 1292 1996 PEDIATRIC INFECTIOUS DISEASE JOURNAL 15(5):465-467 DeVincenzo JP; Burchet SK Prolonged thalidomide therapy for human immunodeficiency virus-associated recurrent severe esophageal and oral aphthous ulcers | 5 | 7 |
| 2354 | 1 | 26 | 2545 2003 PEDIATRIC NEUROLOGY 29(2):151-156 Marjanovic BD; Stojanov LM; Zdravkovic DS; Kravljanac RM; Djordjevic MS Rasmussen syndrome and long-term response to thalidomide | 0 | 0 |
| 2355 | 8 | 31 | 530 1971 PEDIATRIC RESEARCH 5(5):199-& BERAN AV; STRAUSS J; SPERLING DR; NORTON AC; GARWOOD VP; YAMAZAKI J EFFECT OF THALIDOMIDE ON BRAIN OXYGENATION | 0 | 3 |
| 2356 | 1 | 4 | 904 1985 PEDIATRIC RESEARCH 19(4):A324-A324 GARDNER LI; WELSHSLOAN J; CADY RB PHOCOMELIA OF LEFT LOWER LEG IN AN INFANT WHOSE MOTHER TOOK LARGE DOSES OF PYRIDOXINE (B-6) - DEJA VU OF THE THALIDOMIDE DISASTER | 0 | 0 |
| 2357 | 0 | 0 | 1593 1999 PEDIATRIC RESEARCH 45(4):67A-67A Jakkula M; Le Cras TD; Abman SH Effects of fumagillin and thalidomide treatment on alveolarization in the developing rat lung | 0 | 4 |
| 2358 | 0 | 0 | 1782 2000 PEDIATRIC RESEARCH 47(4):264A-264A Hanekom W; Ganiso B; Appolis P; Hughes J; Allin R; Goddard E; Haslett P; Hussey G; Kaplan G Safety and immune effects of thalidomide in HIV-infected children | 0 | 0 |
| 2359 | 2 | 25 | 2278 2002 PEDIATRIC RESEARCH 52(4):576-579 Narita N; Kato M; Tazoe M; Miyazaki K; Narita M; Okado N Increased monoamine concentration in the brain and blood of fetal thalidomide-and valproic acid-exposed rat: Putative animal models for autism | 0 | 3 |
| 2360 | 5 | 14 | 171 1962 PEDIATRICS 30(4):654-& TAUSSIG HB THALIDOMIDE AND PHOCOMELIA | 2 | 12 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2361 | 11 | 13 | 1594 1999 PEDIATRICS 103(4):art. no.-e44 Mehta P; Kedar A; Graham-Pole J; Skoda-Smith S; Wingard JR Thalidomide in children undergoing bone marrow transplantation: Series at a single institution and review of the literature | 0 | 10 |
| 2362 | 10 | 22 | 1595 1999 PEDIATRICS 103(6):1295-1297 Shek LPC; Lee YS; Lee BW; Lehman TJA Thalidomide responsiveness in an infant with Behcet's syndrome | 10 | 16 |
| 2363 | 2 | 37 | 829 1983 PERSPECTIVES IN BIOLOGY AND MEDICINE 27(1):93-106 WYATT HV DID THALIDOMIDE PROMOTE POLIOMYELITIS FOLLOWING ORAL POLIOVIRUS VACCINATION IN WEST-BERLIN IN 1960 | 0 | 4 |
| 2364 | 7 | 24 | 2279 2002 PHARMACEUTICAL RESEARCH 19(1):13-19 Goosen C; Laing TJ; du Plessis J; Goosen TC; Flynn GL Physicochemical characterization and solubility analysis of thalidomide and its N-alkyl analogs | 4 | 4 |
| 2365 | 3 | 21 | 2280 2002 PHARMACEUTICAL RESEARCH 19(4):434-439 Goosen C; Laing TJ; du Plessis J; Goosen TC; Lu GW; Flynn GL Percutaneous delivery of thalidomide and its N-alkyl analogs | 3 | 4 |
| 2366 | 14 | 18 | 2281 2002 PHARMACEUTICAL RESEARCH 19(8):1232-1235 Goosen C; Laing TJ; du Plessis J; Goosen TC; Rao TB; Flynn GL Chemical stabilities and biological activities of thalidomide and its N-alkyl analogs | 3 | 3 |
| 2367 | 0 | 0 | 628 1976 PHARMACOLOGIST 18(2):218-218 HASTINGS RC; MORALES MJ; SHANNON EJ STUDIES ON MECHANISM OF ACTION OF THALIDOMIDE IN LEPROSY | 8 | 11 |
| 2368 | 0 | 0 | 629 1976 PHARMACOLOGIST 18(2):231-231 FABRO S; SHULL G; DIXON R FURTHER-STUDIES ON MECHANISM OF TERATOGENIC ACTION OF THALIDOMIDE | 0 | 0 |
| 2369 | 2 | 6 | 600 1974 PHARMACOLOGY 11(4):193-198 FICKENTS.K; KOHLER F TERATOGENICITY AND EMBRYOTOXICITY OF THALIDOMIDE AND 3-AZA-THALIDOMIDE IN MICE | 0 | 6 |
| 2370 | 5 | 8 | 1596 1999 PHARMACOLOGY & TOXICOLOGY 85(2):103-104 Huang PHT; McBride WG; Tuman WG Interaction of thalidomide with DNA of rabbit embryos: A possible explanation for its immunosuppressant and teratogenic effects | 3 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2371 | 0 | 0 | 2546 2003 PHARMACOPSYCHIATRY 36(5):263-264 Schuld A; Hinze-Selch D; Haack M; Dalal MA; Himmerich H; Lancel M; Pollmacher T Sleep changes following chlorpromazine, clozapine, olanzapine or thalidomide in healthy subjects - First results from a double-blind, placebocontrolled study | 0 | 0 |
| 2372 | 11 | 22 | 1597 1999 PHARMACOTHERAPY 19(10):1177-1180 Horowitz SB; Stirling AL Thalidomide-induced toxic epidermal necrolysis | 10 | 10 |
| 2373 | 11 | 47 | 2282 2002 PHARMACOTHERAPY 22(8):1019-1028 Cool RM; Herrington JD Thalidomide for the treatment of relapsed and refractory multiple myeloma | 1 | 1 |
| 2374 | 0 | 0 | 2283 2002 PHARMACOTHERAPY 22(10):1362-1362 Ando Y; Price DK; Dahut WL; Cox MC; Reed E; Figg WD Pharmacogenetics of thalidomide: drug response, in vivo metabolism and genetic polymorphism of CYP2C19. | 0 | 0 |
| 2375 | 15 | 21 | 2547 2003 PHARMACOTHERAPY 23(3):315-318 Horne MK; Figg WD; Arlen P; Gulley J; Parker C; Lakhani N; Parnes H; Dahut WL Increased frequency of venous thromboembolism with the combination of docetaxel and thalidomide in patients with metastatic androgen-independent prostate cancer | 3 | 4 |
| 2376 | 43 | 78 | 2548 2003 PHARMACOTHERAPY 23(4):481-493 Okafor MC Thalidomide for erythema nodosum leprosum and other applications | 0 | 0 |
| 2377 | 6 | 10 | 557 1972 PHARMAZIE 27(6):418-& MEISE W SYNTHESIS AND TERATOLOGICAL TESTING OF SOME THALIDOMIDE METABOLITES | 2 | 4 |
| 2378 | 2 | 8 | 630 1976 PHARMAZIE 31(7):492-493 OCKENFELS H; KOHLER F; MEISE W TERATOGENIC EFFECT AND STEREOSPECIFICITY OF A THALIDOMIDE METABOLITE | 4 | 9 |
| 2379 | 1 | 9 | 1109 1993 PHARMAZIE 48(2):147-148 HOFENEDER M; KREBS G; SUTTER B; KOCH HP ACUTE TOXICITY OF THALIDOMIDE, TAGLUTIMIDE AND SUPIDIMIDE IN THE YEAST-TEST | 0 | 2 |
| 2380 | 10 | 37 | 2549 2003 PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE 19(6):272-280 Lu KQ; Brenneman S; Burns R; Vink A; Gaines E; Haake A; Gaspari A Thalidomide inhibits UVB-induced mouse keratinocyte apoptosis by both TNF-alpha-dependent and TNF-alpha-independent pathways | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2381 | 0 | 19 | 578 1973 PLASTIC AND RECONSTRUCTIVE SURGERY 51(1):93-95 ELSAHY NI MOBIUS SYNDROME ASSOCIATED WITH MOTHER TAKING THALIDOMIDE DURING GESTATION - CASE REPORT | 0 | 12 |
| 2382 | 2 | 10 | 1997 2001 POLISH JOURNAL OF PHARMACOLOGY 53(6):709-713 Dmoszynska A; Rolinski J; Bojarska-Junak A; Manko J; Jawniak D; Walter-Croneck A; Soroka-Wojtaszko M; Hus M Influence of thalidomide on Bcl(2) expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients | 0 | 0 |
| 2383 | 0 | 1 | 760 1981 POLITICAL QUARTERLY 52(1):135-136 STREET H THE SUNDAY-TIMES THALIDOMIDE CASE - CONTEMPT OF COURT AND THE FREEDOM OF THE PRESS - ROSEN,M | 0 | 0 |
| 2384 | 27 | 43 | 1158 1994 POSTGRADUATE MEDICAL JOURNAL 70(830):860-862 GARDNERMEDWIN JM; POWELL RJ THALIDOMIDE - THE WAY FORWARD | 6 | 9 |
| 2385 | 8 | 13 | 1159 1994 POSTGRADUATE MEDICAL JOURNAL 70(830):901-904 POWELL RJ; GARDNERMEDWIN JMM GUIDELINE FOR THE CLINICAL USE AND DISPENSING OF THALIDOMIDE | 39 | 53 |
| 2386 | 1 | 1 | 1219 1995 POSTGRADUATE MEDICAL JOURNAL 71(832):123-123 JUDGE MR; KOBZABLACK A; HAWK JLM GUIDELINES FOR THE CLINICAL USE AND DISPENSING OF THALIDOMIDE | 0 | 0 |
| 2387 | 73 | 77 | 2550 2003 POSTGRADUATE MEDICAL JOURNAL 79(929):127-132 Gordon JN; Goggin PM Thalidomide and its derivatives: emerging from the wilderness | 0 | 3 |
| 2388 | 0 | 0 | 350 1965 POSTGRADUATE MEDICINE 38(4):A162-& [Anon] THALIDOMIDE LEGACY | 0 | 0 |
| 2389 | 0 | 0 | 252 1963 POULTRY SCIENCE 42(5):1257-& BOONE MA; HAMMOND M; BARNETT BD EFFECT OF THALIDOMIDE ON DOMESTIC FOWL | 2 | 0 |
| 2390 | 0 | 0 | 253 1963 POULTRY SCIENCE 42(5):1293-& NABER EC; LARGENT EJ MALFORMATIONS INDUCED BY THALIDOMIDE IN DEVELOPING CHICK EMBRYO | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 2391 | 2 | 2 | 254 1963 POULTRY SCIENCE 42(6):1479-& BLOW WL; COOK FW; KARE MR EFFECTS OF THALIDOMIDE ON REPRODUCTION IN CHICKENS | 1 | 1 |
| 2392 | 3 | 7 | 298 1964 POULTRY SCIENCE 43(2):506-& BOONE MA; BARNETT BD; HAMMOND M EFFECT OF THALIDOMIDE ON CHICKENS + EMBRYOS | 1 | 3 |
| 2393 | 7 | 10 | 299 1964 POULTRY SCIENCE 43(6):1420-& KONDRA PA; SELL JL; MCKIRDY JA EFFECT OF THALIDOMIDE ON REPRODUCTION IN HEN | 2 | 4 |
| 2394 | 13 | 27 | 351 1965 POULTRY SCIENCE 44(6):1583-& NABER EC; LARGENT EJ THALIDOMIDE TERATOGENESIS IN DEVELOPING CHICK EMBRYO AND ITS RELATIONSHIP TO VITAMIN METABOLISM | 1 | 2 |
| 2395 | 4 | 9 | 601 1974 PRACTITIONER 212(1269):296-297 ROE FJC RESEARCH ON ANTICARCINOGENIC EFFECTS OF THALIDOMIDE | 0 | 0 |
| 2396 | 0 | 3 | 761 1981 PRACTITIONER 225(1355):721-& QUIBELL EP THE THALIDOMIDE EMBRYOPATHY - AN ANALYSIS FROM THE UK | 9 | 13 |
| 2397 | 0 | 1 | 787 1982 PRAXIS DER KINDERPSYCHOLOGIE UND KINDERPSYCHIATRIE 31(6):250-250 BIERMANN G THE ADOLESCENCE OF THALIDOMIDE DAMAGED CHILDREN - GERMAN - JOCHMUS,I, SCHMIDT,GM, LOHMAR,L, LOHMAR,W | 0 | 0 |
| 2398 | 1 | 2 | 949 1987 PRENATAL DIAGNOSIS 7(4):295-298 GOLLOP TR; EIGIER A PRENATAL-DIAGNOSIS OF THALIDOMIDE SYNDROME | 5 | 6 |
| 2399 | 3 | 10 | 172 1962 PRESSE MEDICALE 70(31):1521-& TUCHMANNDUPLESSIS A PROPOS DES MALFORMATIONS ATTRIBUEES A UN SOMNIFERE LA THALIDOMIDE | 0 | 0 |
| 2400 | 0 | 3 | 173 1962 PRESSE MEDICALE 70(41):1899-& VAILLE C EN MARGE DE LAFFAIRE DU THALIDOMIDE - QUELQUES ASPECTS PSYCHOLOGIQUES | 0 | 1 |
Page 8: 1 2 3 4 5 6 7 8 9
Generated by: HistCite(Vlad).
Version: 2004.09.22